LEXX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lexaria Bioscience Corp

Watchlist Manager

Watchlist

Price: 5.27 USD -1.31% Market Closed

Market Cap: $8.7m

	Lexaria Bioscience Corp NASDAQ:LEXX	CA
T	Tokio Marine Holdings Inc DUS:MH6	JP
	Grindrod Ltd OTC:GRDLF	ZA
	Audax Renovables SA F:54F	ES

Profitability Summary

Lexaria Bioscience Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

97%

Gross Margin is Increasing

79% > 100%

Negative Operating Margin

-3 973%

Negative 3Y Average Operating Margin

-2 025%

Declining Operating Margin

-2 050% > -3 973%

Negative Net Margin

-3 986%

Negative 3Y Average Net Margin

-2 035%

Declining Net Margin

-2 029% > -3 986%

Negative Free Cash Flow Margin

-3 954%

Negative 3Y Average Free Cash Flow Margin

-1 894%

Declining Free Cash Flow Margin

-1 644% > -3 954%

Negative ROE

-150%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-663%

Declining ROIC

-553% > -598%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.